ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

GTHX G1 Therapeutics Inc

4.27
0.00 (0.00%)
プレマーケット
最終更新日: 20:57:16
15分遅延
名称 銘柄コード 市場 種別
G1 Therapeutics Inc GTHX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.27 20:57:16
始値 安値 高値 終値 前日終値
4.27
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0206:50GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2024/5/0119:30GLOBEG1 Therapeutics Provides First Quarter 2024 Financial..
2024/5/0119:25GLOBEG1 Therapeutics and Pepper Bio Announce Global (Excluding..
2024/4/1722:00GLOBEG1 Therapeutics to Release First Quarter 2024 Financial..
2024/4/0423:30GLOBEG1 Therapeutics to Participate in the 23rd Annual Needham..
2024/4/0205:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2024/3/0206:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2024/2/2820:35EDGAR2Form 8-K - Current report
2024/2/2820:30GLOBEG1 Therapeutics Provides Fourth Quarter and Full Year 2023..
2024/2/2722:30GLOBEG1 Therapeutics to Participate in the TD Cowen 44th Annual..
2024/2/1522:30GLOBEG1 Therapeutics to Release Fourth Quarter and Full Year 2023..
2024/2/1408:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:42EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1306:19EDGAR2Form 8-K - Current report
2024/2/1306:05GLOBEG1 Therapeutics to Continue Pivotal Phase 3 Trial of..
2024/1/1006:19EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0820:45GLOBEG1 Therapeutics Provides Corporate Update at the 42nd Annual..
2024/1/0820:30EDGAR2Form 8-K - Current report
2024/1/0820:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0323:00GLOBEG1 Therapeutics to Participate in the 42nd Annual J.P...
2024/1/0309:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:51GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2023/12/1406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1306:40EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1208:43EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0523:26GLOBEG1 Therapeutics Presents New Post Hoc Analyses Indicating..
2023/12/0206:27GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2023/11/3010:37GLOBEG1 Therapeutics Announces Upcoming Presentation at the 2023..
2023/11/0205:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/11/0205:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0119:46EDGAR2Form 8-K - Current report
2023/11/0119:30GLOBEG1 Therapeutics Provides Third Quarter 2023 Financial..
2023/10/2720:00GLOBEReal World Data Indicate That Trilaciclib Reduces..
2023/10/1821:00GLOBEG1 Therapeutics’ COSELA® (trilaciclib) Recommended in..
2023/10/1820:30GLOBEG1 Therapeutics to Release Third Quarter 2023 Financial..
2023/10/1622:00GLOBEG1 Therapeutics Announces Upcoming Presentations at the 2023..
2023/9/2205:15EDGAR2Form 8-K - Current report
2023/9/1820:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
2023/9/0600:00GLOBEG1 Therapeutics to Participate in the H.C. Wainwright 25th..
2023/9/0205:15GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
2023/8/1105:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0908:28EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0219:50EDGAR2Form 8-K - Current report
2023/8/0219:30GLOBEG1 Therapeutics Provides Second Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock